Cardizem LA

Bausch Health US LLC🇺🇸 United States

FDA Page

Effective Date: Apr 1, 2025
Approval ID: 3e180dc7-c871-4efc-8755-cae882976c8d
Products: 6 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CARDIZEM LA safely and effectively. See full prescribing information for CARDIZEM LA. CARDIZEM® LA (diltiazem hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 1982

Quick Stats

Total Products6

Labelers2

Label Sections37

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.